Home
>
National Drug Code (NDC)
>
Depacon
Depacon - 0074-1564-10 - (Valproate Sodium)
Drug Information of Depacon
| Product NDC: | 0074-1564 |
| Proprietary Name: | Depacon |
| Non Proprietary Name: | Valproate Sodium |
| Active Ingredient(s): | 100 mg/mL & nbsp; Valproate Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Depacon
| Product NDC: | 0074-1564 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020593 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961230 |
Package Information of Depacon
| Package NDC: | 0074-1564-10 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0074-1564-10) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Depacon
| NDC Code | 0074-1564-10 |
| Proprietary Name | Depacon |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0074-1564-10) > 5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0074-1564 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Valproate Sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19961230 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | VALPROATE SODIUM |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
